Scope Fluidics S.A. Logo

Scope Fluidics S.A.

Biotechnology firm that incubates and sells microfluidic diagnostic projects.

SCP | WAR

Overview

Corporate Details

ISIN(s):
PLSCPFL00018
LEI:
259400EUNFX4E2BEHU15
Country:
Poland
Address:
WARSZAWA OGRODOWA 58, 00-876 WARSZAWA

Description

Scope Fluidics S.A. is a biotechnology company that develops innovative medical diagnostic solutions based on microfluidic technologies. The company's business model involves incubating projects within special-purpose vehicles (SPVs) with the goal of selling them to global strategic partners. Its primary project, developed by its subsidiary Bacteromic Sp. z o.o., is the BACTEROMIC system. This automated system provides rapid, comprehensive antimicrobial susceptibility testing (AST) to address the challenge of antibiotic resistance. Previously, the company developed the PCR|ONE system for rapid molecular diagnostics through its Curiosity Diagnostics SPV, which was acquired by Bio-Rad in 2022. The company focuses on creating fast, effective, and accessible diagnostic tools to improve healthcare outcomes.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2024-08-22 11:03
Warunkowa decyzja Państwowego Urzędu Własności Intelektualnej Chin o przyznaniu…
Polish HTML 1.8 KB
2024-06-28 13:18
Wykaz akcjonariuszy posiadających co najmniej 5% liczby głosów na Zwyczajnym Wa…
Polish PDF 47.1 KB
2024-06-28 13:18
Wykaz akcjonariuszy posiadających co najmniej 5% liczby głosów na Zwyczajnym Wa…
Polish HTML 335 bytes
2024-06-25 16:02
Informacje dot.Patryka Mikuckiego
Polish PDF 78.5 KB
2024-06-25 16:02
Powołanie członka Rady Nadzorczej - Content (PL)
Polish HTML 430 bytes
2024-06-25 15:57
Treść uchwał podjętych przez ZWZ Spółki w dniu 25 czerwca 2024 r.
Polish PDF 197.0 KB
2024-06-25 15:57
Treść uchwał podjętych przez ZWZ Spółki w dniu 25 czerwca 2024 r. - Content (PL)
Polish HTML 659 bytes
2024-06-21 17:07
Zakwalifikowanie projektu DSC001 do rozwoju w ramach spółki celowej - Content (…
Polish HTML 4.5 KB
2024-06-04 09:47
Informacja o warunkowej decyzji Urzędu Patentów i Znaków Towarowych Stanów Zjed…
Polish HTML 1.8 KB
2024-05-29 12:26
Sprawozdaie Rady Nadzorczej z działalności za 2023 rok
Polish PDF 171.7 KB
2024-05-29 12:26
Wniosek Zarządu Scope Fluidics S.A. do ZWZ dot. pokrycia straty za 2023 r.
Polish PDF 150.9 KB
2024-05-29 12:26
Projekty uchwał ZWZ Scope Fluidics S.A. zwołanego na 25 czerwca 2024 r.
Polish PDF 216.6 KB
2024-05-29 12:26
Ogłoszenie o zwołaniu ZWZ Scope Fluidics S.A. na dzień 25 czerwca 2024 r.
Polish PDF 241.1 KB
2024-05-29 12:26
Zwołanie Zwyczajnego Walnego Zgromadzenia Scope Fluidics S.A. na 25 czerwca 202…
Polish HTML 918 bytes
2024-05-29 08:21
Skonsolidowany "rozszerzony" raport GK Scope Fluidics S.A. za I kwartał 2024 r.
Polish PDF 1.4 MB

Automate Your Workflow. Get a real-time feed of all Scope Fluidics S.A. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Scope Fluidics S.A.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Scope Fluidics S.A. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

1NKEMIA Logo
Biotechnology company providing R&D and services for the life sciences sector.
Spain
IKM
2cureX AB Logo
Develops an IVD test using 3D tumoroids to predict patient response to cancer drugs.
Sweden
2CUREX
Abera Bioscience AB Logo
Develops mucosal vaccines using a proprietary Outer Membrane Vesicle (OMV) platform.
Sweden
ABERA
Clinical-stage biopharma developing therapeutics for oncology and viral diseases.
South Korea
203400
ABL Bio Inc. Logo
Develops bispecific antibody therapeutics for oncology and neurodegenerative diseases.
South Korea
298380
Abpro Holdings, Inc. Logo
Clinical-stage biotech developing antibody therapeutics for oncology and ophthalmology.
United States of America
ABP
Absci Corp Logo
A generative AI drug creation company developing biologic medicines.
United States of America
ABSI
Achiko AG Logo
A digital services platform for cross-border business compliance and engagement.
Switzerland
ACHI
Active Biotech Logo
Biotechnology company developing drugs for oncology and inflammatory eye disorders.
Sweden
ACTI
Adagene Inc. Logo
Clinical-stage biotech developing antibody-based immunotherapies for oncology.
United States of America
ADAG

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.